Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 3 Cancer Trials

Phase 3 cancer studies

Phase 3 cancer trials, on your terms

You can learn about Phase 3 cancer trials here, for yourself or someone you care for. If one interests you, Phase 3 Cancer Trials connects you with the study team. A short conversation comes first. It costs you nothing and commits you to nothing.

Call (888) 306-7888
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed
A long, bright hospital corridor
Photo by Burçak Çubukçu on Pexels
All locations

Phase 3 cancer studies in numbers

Phase 3 cancer studies recruiting in the U.S.
273
states with a study site
51
cities with a study site
1,386
studies that accept healthy volunteers
2

Source: ClinicalTrials.gov. Data processed .

Find Phase 3 cancer studies near you

These states have the most studies recruiting right now.

Phase 3 cancer studies recruiting now

As of November 18, 2026, 273 Phase 3 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry. This is what they have in common.

What they test

  • medications229
  • biologics such as vaccines or antibodies57
  • other approaches55
  • procedures49
  • radiation27

A study can test more than one.

Main purpose

  • treating a condition247
  • supportive care9
  • diagnosis8
  • prevention5

Phase

  • Phase 2/333
  • Phase 3240

Who runs them

  • industry180
  • university, hospital or other82
  • government11

Who they enroll

  • adults (18 to 64)269
  • older adults (65 and over)265
  • mainly children and teens (under 18)1

2 also accept healthy volunteers.

Where: sites in 51 states. The cities with the most are New York, NY (121), Houston, TX (111), Los Angeles, CA (95), Chicago, IL (94), Nashville, TN (86), St Louis, MO (80), Boston, MA (79), Atlanta, GA (76).

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 273 studies.

Recruiting now, by research area

Recently updated Phase 3 cancer studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Ames, IA · Anaconda, MT · Ankeny, IA · and 210 more U.S. locations
    Registry record
    NCT06337318 · updated
  2. Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Abilene, TX · Albuquerque, NM · Alexandria, LA · and 69 more U.S. locations
    Registry record
    NCT06393374 · updated
  3. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    ‘Aiea, HI · ‘Ewa Beach, HI · Aberdeen, MD · and 223 more U.S. locations
    Registry record
    NCT06498635 · updated
  4. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Abilene, TX · Alameda, CA · Anaheim, CA · and 86 more U.S. locations
    Registry record
    NCT06767514 · updated
  5. Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Recruiting in
    Anchorage, AK · Atlanta, GA · Bay Pines, FL · and 22 more U.S. locations
    Registry record
    NCT06899126 · updated
  6. Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Abilene, TX · Amarillo, TX · Atlanta, GA · and 17 more U.S. locations
    Registry record
    NCT07195695 · updated

Source: ClinicalTrials.gov. Data processed .

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry.

Phase 3 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Not sure which study fits?

Tell a coordinator what you are looking for. They will explain which Phase 3 cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.

Call (888) 306-7888

How taking part works

There are four steps. At each one, going further is your decision.

  1. Tell us what you are looking for

    Reach us by phone or with a short form. Tell us the type of cancer or the Phase 3 study you have in mind.

  2. Talk with a coordinator

    You talk with a coordinator about which Phase 3 cancer trials could fit your situation. Ask whatever is on your mind. The coordinator replies in clear, everyday words.

  3. Meet the study team

    Going further is your call. Say yes, and the team behind that Phase 3 trial takes you through its specifics step by step. Checking your eligibility is part of their job too.

  4. Decide what is right for you

    Whether you take part is always up to you. You are free to change your mind. Leaving a study is possible at any time, whatever your reason.

Research areas

These are the areas of cancer where we help you explore Phase 3 studies.

  • Breast Cancer studies

    Find the Phase 3 breast cancer studies recruiting right now, along with their locations.

  • Lung Cancer studies

    Find the Phase 3 lung cancer studies recruiting right now, along with their locations.

  • Prostate Cancer studies

    Find the Phase 3 prostate cancer studies recruiting right now, along with their locations.

  • Melanoma studies

    Find the Phase 3 melanoma studies recruiting right now, along with their locations.

  • Lymphoma studies

    Find the Phase 3 lymphoma studies recruiting right now, along with their locations.

  • Pancreatic Cancer studies

    Find the Phase 3 pancreatic cancer studies recruiting right now, along with their locations.

  • Not sure where you fit?

    Share a few words about what you are looking for. A coordinator will then guide you toward the right place.

Why people take part in Phase 3 cancer studies

People take part in Phase 3 cancer trials for different reasons. Whatever yours is, it is a good one to talk through before you decide.

  • You may want a research team following your health closely while the study runs.
  • You may want to understand more about a cancer you live with.
  • You may want to help researchers answer questions that could shape future care for others.

Keep in mind that a study is research. It is not treatment. Nobody can promise that joining will help you personally. For a plain explanation, read what a clinical trial is.

Your safety and your rights come first

Before a Phase 3 cancer trial can enroll a single person, an independent ethics committee must review it. The details reach you in writing first, and only then are you asked to agree. To learn more, start with how informed consent works. Then see who reviews and monitors a trial, and the rights that stay with you throughout.

Common questions about Phase 3 cancer studies

Does it cost anything to ask about a study?

No. You pay nothing to talk with Phase 3 Cancer Trials. Asking questions does not enroll you in anything.

Do I have to take part if I call?

No. Each step is yours to accept or decline. Stopping is possible whenever you choose.

Who decides whether I can join a study?

That decision belongs to the study team, and it comes after you attend a screening visit. No two Phase 3 cancer trials set identical requirements. Find out what screening involves.

Ask about Phase 3 cancer studies

A little information about you is enough to start. From there, a coordinator contacts you about Phase 3 cancer trials. Your question carries no obligation of any kind.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Learn more from independent sources

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 306-7888

or send a short form

How should we reach you?

Call